Success Metrics

Clinical Success Rate
78.6%

Based on 22 completed trials

Completion Rate
79%(22/28)
Active Trials
11(21%)
Results Posted
9%(2 trials)
Terminated
6(11%)

Phase Distribution

Ph phase_1
1
2%
Ph phase_3
1
2%
Ph not_applicable
19
36%
Ph phase_4
3
6%
Ph phase_2
1
2%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution25 total trials
Phase 1Safety & dosage
1(4.0%)
Phase 2Efficacy & side effects
1(4.0%)
Phase 3Large-scale testing
1(4.0%)
Phase 4Post-market surveillance
3(12.0%)
N/ANon-phased studies
19(76.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.0%

22 of 31 finished

Non-Completion Rate

29.0%

9 ended early

Currently Active

11

trials recruiting

Total Trials

53

all time

Status Distribution
Active(13)
Completed(22)
Terminated(9)
Other(9)

Detailed Status

Completed22
unknown9
Recruiting9
Terminated6
Withdrawn3
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
53
Active
11
Success Rate
78.6%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (4.0%)
Phase 21 (4.0%)
Phase 31 (4.0%)
Phase 43 (12.0%)
N/A19 (76.0%)

Trials by Status

active_not_recruiting24%
terminated611%
completed2242%
unknown917%
recruiting917%
withdrawn36%
enrolling_by_invitation12%
not_yet_recruiting12%

Recent Activity

Clinical Trials (53)

Showing 20 of 53 trialsScroll for more
NCT06652763

Manganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction

Recruiting
NCT04584541Not Applicable

SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism

Terminated
NCT05659147Phase 4

Imaging Biomarkers of Pancreatic Function and Disease

Enrolling By Invitation
NCT04827563

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

Terminated
NCT04439370

Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women

Recruiting
NCT01492036

Long-Term Follow-Up of Recipient of Gene Transfer Research

Recruiting
NCT00639964Not Applicable

Exploration of the Lipid Metabolism During the Diabetic Pregnancies

Completed
NCT06698614

MEMRI and Kidney Disease

Recruiting
NCT06180278Phase 4

Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Active Not Recruiting
NCT04681573Not Applicable

Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLD

Recruiting
NCT04232293Not Applicable

Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus

Completed
NCT02390297

Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients

Active Not Recruiting
NCT04880317Not Applicable

Validation of Quantitative Myocardial Tissue Characterization Through Non-gated CT

Terminated
NCT06630637Not Applicable

Monitoring Intermittent Fasting for Human Optimization Using Wearable Technology: An N-of-1 Study

Completed
NCT06156046

Tolerance in Beekeepers

Recruiting
NCT03868046

Autoantibodies in Treatment with Immune Checkpoint Inhibitors (AUTENTIC)

Completed
NCT05378035

DOAC in Chinese Patients With Atrial Fibrillation

Recruiting
NCT04986917Not Applicable

Laparoscopic Ventral Hernia Repair with Routine Defect Closure Using Su2ura® Approximation Device

Completed
NCT06363903

ASIA-Mesh: a Pilot Study for Diagnostics and Treatment on ASIA Syndrome Caused by Polypropylene Mesh Implantation

Recruiting
NCT05642273Not Applicable

The Effects of oXiris in Cardiogenic Shock Requiring VA-ECMO

Completed

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
53